Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

CEL-SCI Expands Testing Of Its Vaccine To Determine Efficacy Against More Virulent Strain Of H1N1 Swine And Other Influenza Viruses
CEL-SCI Corporation (NYSE Amex: CVM) announced that it is expanding the pre-clinical testing of its flu vaccine, utilizing its proprietary L.E.A.P.S. technology (Ligand Epitope Antigen Presentation System) to determine its efficacy against the more dangerous and virulent virus strains that may arise during the up coming winter flu season. The Company has begun pre-clinical formulation, evaluation and testing of a new application of its L.E.A.P.S vaccine, which will allow the targeting of "mutated" versions of H1N1 swine and other influenza viruses. It is believed that the influenza virus may mutate and evolve between now and the winter flu season. In conjunction with the testing, CEL-SCI has produced several L.E.A.P.S. flu vaccines that focus on the conserved, non changing epitopes of the different strains of Type A Influenza viruses (H1N1, H5N1, H3N1, etc.), including "swine", "avian or bird", and "Spanish Influenza", in order to minimize the chance of viral "escape by mutations" from immune recognition. CEL-SCI"s L.E.A.P.S. flu vaccine contains epitopes known to be associated with immune protection against influenza in animal models. The Company had previously announced that it had begun pre-clinical testing of swine and H1N1 flu viruses, which were non-mutated versions of the virus.

Children's Hospital Oakland Scientists First To Discover New For Harvesting Stem Cells
A groundbreaking study conducted by Children"s Hospital & Research Center Oakland is the first to reveal a new avenue for harvesting stem cells from a woman"s placenta, or more specifically the discarded placentas of healthy newborns. The study also finds there are far more stem cells in placentas than in umbilical cord blood, and they can be safely extracted for transplantation. Furthermore, it is highly likely that placental stem cells, like umbilical cord blood and bone marrow stem cells, can be used to cure chronic blood-related disorders such as sickle cell disease, thalassemia, and leukemia.
News of the day
National Organization For Rare Disorders To Honor Rare Disease Pioneers
The National Organization for Rare Disorders (NORD) will honor a senior U.S. Senator, a top Administration official, a cutting-edge television network, and several pioneering companies developing treatments for rare diseases at the 2009 NORD Gala at the National Press Club in Washington, DC, on Thursday, May 14.
Nutrition

Second Edition Of 'Medical Ultrasound Safety' Released By AIUM

The American Institute of Ultrasound in Medicine is pleased to announce the release of Medical Ultrasound Safety, Second Edition. All operators of ultrasound systems with an output display should review the information in this publication. The book consists of 3 parts: Bioeffects and Biophysics, Prudent Use, and Implementing ALARA (as low as reasonably achievable). With the information from this 64 page publication, users can better control the diagnostic ultrasound equipment and examination to ensure that needed diagnostic information is obtained with minimal risk to the patient. A new feature of this edition is the inclusion of a CME self-study test at the end of each section. Individuals who successfully complete all 3 self-study tests can earn up to 3 AMA PRA Category 1 Credits™ (accepted by the ARDMS) or ARRT Category A Credits. Fees for CME credits apply, and instructions for test submission are included within the publication. Over 140,000 copies of the first edition have been sold since 1994, attesting to the popularity and critical nature of the publication. Marvin C. Ziskin, MD, Chairman of the Revision Task Force, states in the preface to the second edition that "Many technological advances in ultrasonic scanning have occurred since the publication of the first edition". Ziskin goes on to emphasize the importance of education and awareness in health care practice to ensure its safe and practical use: "The improved instrumentation has fostered an ever-increasing range of clinical applications. Ultrasound imaging has become an integral part of virtually all areas of medicine. The number of ultrasound examinations has continually increased and is now in the millions each year. Along with this increased use there is a significant benefit to more patients, but at the same time more individuals are exposed to greater amounts of ultrasound energy. Furthermore, some new techniques, such as the introduction of contrast agents, significantly increase the risk of possible harmful effects from ultrasound examinations. Health care professionals need to be concerned that patients are not exposed to any unnecessary risk. The purpose of this manual is to help the health professional be aware of the potential harmful effects of ultrasound and how to minimize their occurrence." The US Food and Drug Administration (FDA) Center for Devices and Radiological Health suggests to manufacturers that they provide a copy of Medical Ultrasound Safety with ultrasound equipment they sell. This publication meets the FDA recommendations (Track 3.4.1) for education programs for the clinical end-user. A licensing agreement for Medical Ultrasound Safety is available for manufacturers. Medical Ultrasound Safety may be purchased online through the AIUM website at http://www.aium.org. The American Institute of Ultrasound in Medicine is a multidisciplinary association dedicated to advancing the safe and effective use of ultrasound in medicine through professional and public education, research, development of guidelines, and accreditation. Jennifer Hilderbrand American Institute of Ultrasound in Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009